Clinical Trial Update: Evaluation of Efficacy and Safety for Single Dose of E004 in Children With Asthma [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy and safety of a single-dose E004 in children with asthma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• E004

Snippet

Sponsor: Amphastar Pharmaceuticals, Inc. | Conditions: Asthma | Phase 3 | Status: COMPLETED